latest developments in ptcl treatment
Published 2 years ago • 104 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
2:27
the current standard of care for patients with ptcl
-
1:15
the current status of autologous transplantation in ptcl
-
0:51
the need for novel agents for the treatment of ptcl
-
2:57
lacutamab, an anti-kir3dl2 monoclonal antibody, in the treatment of r/r ptcl
-
1:55
the real-world efficacy of brentuximab vedotin consolidation post-autosct in r/r hl
-
1:02
the changing standard of care in dlbcl
-
55:54
management of peripheral t-cell lymphoma
-
6:24
indiko biochemistry analyzer demonstration
-
4:59
bone marrow transplant: one procedure, three different patient journeys
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:11
precision medicine in sickle cell disease: current status and future outlooks
-
3:52
updates on the use of car-t therapy for the treatment of dlbcl in the second-line setting
-
6:47
immunoepigenetic platforms for ptcl treatment
-
4:42
ptcl arising as a ptld: the efficacy of pralatrexate
-
2:41
improved outcomes in ptcl with the use of novel agents and transplantation
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
0:45
difference between quality of life & patient-reported outcomes
-
1:23
the current treatment landscape for patients with t-cell prolymphocytic leukemia
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:38
car-t therapy for aggressive b-cell lymphomas